Nkarta, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul J. Hastings, with a market cap of $218.9M.
Based on Q1 2026 filing
Common questions about Nkarta, Inc.
Nkarta, Inc. (NKTX) has a market capitalization of $218.9M and trades on NASDAQ.
Nkarta, Inc. has approximately 150 employees.